Reducing Exacerbations in COPD: Implementing Updated Guidelines and Care Coordination to Prevent Rehospitalization

 


A series of Live Grand Rounds Presentations

Welcome to "Reducing Exacerbations in COPD: Implements Updated Guidelines and Care Coordination to Prevent Rehospitalization.” A series of live CME-certified in-hospital presentations will be held at locations nationwide in 2018.

PROGRAM OVERVIEW
Publication of the recently updated Global Initiative for Chronic Obstruction Lung Disease (GOLD) Report creates an urgent need to disseminate the most current evidence-based recommendations to improve pharmacologic and non-pharmacologic management of COPD. Appropriate management of COPD can reduce the rate of admissions and readmissions for an exacerbation. However, care coordination is inadequate and patients are often insufficiently engaged in their care and lack the ability to self-manage their condition.

Reducing Exacerbations in COPD: Implementing Updated Guidelines and Care Coordination to Prevent Rehospitalization will provide clinicians with the most up-to-date evidence- and guideline-based recommendations for treating COPD. Participating clinicians will be better able to manage their patients, reduce the risk of exacerbations, and improve the overall care of COPD.

TARGET AUDIENCE
This activity is intended for hospital-based clinicians who manage patients with COPD, including internists, primary care physicians, pulmonologists, respiratory therapists, RNs, PAs, pharmacists, and behavioral health professionals.

EDUCATIONAL OBJECTIVES
This program is designed to address the following IOM competencies: provide patient-centered care and employ evidence-based practice.         

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Utilize guideline-concordant maintenance pharmacotherapy, along with appropriate nonpharmacologic strategies, to reduce exacerbation risk and improve quality of life in patients with COPD
  • Educate patients regarding appropriate self-management techniques to reduce COPD exacerbations, utilizing an interprofessional care team to optimize patient engagement

ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION
Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FEE AND RECEIVING CME/CE CREDIT
There is no fee for this educational activity. To receive CME/CE credit the participant must:

  • Participate in this one-hour-long program;
  • Sign in on the sheet provided by the host coordinator;
  • Complete the evaluation forms;
  • Return the evaluation forms to the host coordinator.

AGENDA

  • Welcome, Introduction, and Pre-Survey
  • Guidline-concordant Pharmacologic and Nonpharmacologic COPD Management
  • Optimizing Self-managementand Patient engagement in COPD
  • Mini Case Series
  • Q&A Session and Activity Roundup

BOSTON UNIVERSITY SCHOOL OF MEDICINE DISCLAIMER
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

DISCLOSURE INFORMATION
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

Steering Committee

The steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests: 

Mark. T. Dransfield, MDAdvisory Board: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Proterrix Bio; Study Steering Committee: AstraZeneca/Pearl. GlaxoSmithKline; Speaker: AstraZeneca, Boehringer Ingelheim, Novartis; Data and Safety Monitoring Board: Genentech, GlaxoSmithKline 

Fernando J. Martinez, MD, MS: Consultant: AstraZeneca, Boehringer Ingelheim, Genentech, GlaxoSmithKline; PneumRx/BTG; Grant/Research Support: AstraZeneca, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Novartis, PneumRx/BTG, Pulmonx

Caroline Gainer: Nothing to Disclose 

Non-faculty Content Contributors

Hasmeena Kathuria, MD (CME Course Director): Nothing to Disclose 

Kathy Merlo, CHCP; Nicolle Rochino, PharmD, RPh; Blair St. Amand; Elizabeth Drury; Natalie Sanfratello, MPH; Lindsay  Scott, PT, DPT, ATC: Nothing to Disclose

FDA DISCLOSURE
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

LIVE PROGRAM SCHEDULE
​If you are interested in attending or scheduling a meeting in your local area, please contact Kathy Whyte at 443-909-7901 or kwhyte@rockpointe.com 

LIVE PROGRAM MATERIALS FOR SPEAKERS AND ADMINISTRATORS 

I. Administrator Material

Program Poster (PDF)

Program Flyer (PDF)

Program Syllabus (PDF)

Slide Handout – black & white (PDF)

II. Speaker Material

Thank you for joining us as an expert speaker for the grand rounds series, Reducing Exacerbations in COPD: Implementing Updated Guidelines and Care Coordination to Prevent Rehospitalization."

CME-certified Program Slides that have been reviewed and approved and are to be used for this activity. 

STEERING COMMITTEE

 MARK T. DRANSFIELD, MD
 Professor of Medicine
 William C. Bailey, MD Endowed Chair in Pulmonary Disease
 Division of Pulmonary, Allergy, and Critical Care Medicine
 University of Alabama at Birmingham
 Birmingham VA Medical Center
 Birmingham, AL

Mark T. Dransfield, MD is the William C. Bailey, MD Endowed Chair in Pulmonary Disease and Professor of Medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine at the University of Alabama at Birmingham (UAB). Dr. Dransfield is also a staff physician at the Birmingham VA Medical Center. He completed his medical doctorate at the University of North Carolina at Chapel Hill, followed by a residency in internal medicine and a fellowship in pulmonary and critical care at UAB, where he served as Chief Fellow. He has been on the faculty at UAB since 2003 and serves as the Medical Director of the UAB Lung Health Center and the Medical Director of Pulmonary Rehabilitation.

Dr. Dransfield has been named one of America’s Best Doctors from 2010 to 2018. His primary clinical and research interest is chronic obstructive pulmonary disease (COPD) and he directs the UAB/Centers for Medicare and Medicaid COPD Bundled Payments for Care Improvement (BPCI) initiative. He is Principal Investigator for multiple translational studies and clinical trials at the UAB Lung Health Center, including the Department of Defense‐sponsored Beta‐Blockers for the Prevention of Acute Exacerbations of COPD study, as well as the NIH‐sponsored COPD Gene and SPIROMICS studies. He has published more than 125 research papers focusing on COPD-related epidemiology, comorbid illnesses, pathophysiology, and therapeutics.

 FERNANDO J. MARTINEZ, MD, MS
 Chief, Pulmonary and Critical Care Medicine
 Bruce Webster Professor of Medicine
 Joan and Sanford I. Weill Department of Medicine
 Weill Cornell Medical College
 New York-Presbyterian Hospital/Weill Cornell Medical Center
 New York, NY

Fernando J. Martinez, MD, MS is Chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medical College in New York City. Prior to this appointment, he was Professor of Internal Medicine and Associate Chief for Clinical Research in the Division of Pulmonary and Critical Care Medicine at the University of Michigan Health System in Ann Arbor, MI, as well as Medical Director of its Pulmonary Diagnostic Services and Co-medical Director of the Lung Transplantation Program. After graduating from the University of Florida School of Medicine in Gainesville, FL, he completed a residency in internal medicine at Beth Israel Hospital in Boston, MA, and a fellowship in pulmonary medicine at the Boston University Pulmonary Center. He received a Master’s in Biostatistics and Clinical Study Design from the University of Michigan School of Public Health.

Dr. Martinez’s main research interests include the biological underpinnings and therapeutic approaches to interstitial lung diseases and chronic obstructive pulmonary disease (COPD). He is a member of numerous societies, including the American Thoracic Society, European Respiratory Society, and American College of Chest Physicians. Previously, he was a member of the American Thoracic Society Committees, which generated guidelines for the management of COPD, respiratory infections, idiopathic pulmonary fibrosis, and cardiopulmonary exercise testing. He is the former Chair of the Clinical Problems Assembly of the American Thoracic Society. Dr. Martinez is a member of the GOLD Science Committee and sits on a number of editorial boards, including for Journal of COPD and American Journal of Respiratory and Critical Care Medicine. He serves as a Deputy Editor for the latter.

PATIENT ADVISER

 CAROLINE GAINER
 Contributor, COPD360Social
 COPD Advocacy Advisor and West Virginia Team Captain
 COPD Foundation

 

 

 

Caroline Gainer is a retired public-school teacher with 38 years of service in the public schools of West Virginia. She has a degree in biology, health, and physical education from Glenville State College and a Master’s in math from Marshall University. Upon retiring from the public-school system, Caroline taught math at a local community college and served as the Jewelry Coordinator for a large corporation. She retired from both of those positions in March of 2016.

Caroline received a diagnosis of COPD in August of 2013 and was admitted to the hospital with a pneumothorax the following month. She has since dedicated her time to learning how to manage her condition and to live life to the fullest. Caroline is a frequent contributor to the COPD360Social page, which is housed in the COPD Foundation website. She is also a member of the Advocacy Team and serves as one of the State Captains for the state of West Virginia.

CME COURSE DIRECTOR                                  

HASMEENA KATHURIA, MD
Assistant Professor, Medicine
Boston University School of Medicine
Boston, MA

 

 

Hasmeena Kathuria, MD is a pulmonary and critical care physician, a sleep physician, and an expert in tobacco-dependence treatment. She has developed and directs the Tobacco Treatment Center at Boston Medical Center (BMC), a program that brings together a multidisciplinary team of health professionals who specialize in helping smokers quit smoking. In addition, she is a member of the BMC sleep group and has expertise in the diagnosis and treatment of sleep disorders. 

Dr. Kathuria received the inaugural Clinical Innovator Award and the BMC Clinical “Be Exceptional” Award, relating to her efforts to treat tobacco dependence in low SES populations. For her work related to tobacco treatment, she was appointed by the American Thoracic Society to serve on the Tobacco Action Committee to help organize research, clinical, educational, advocacy, and policy activities relating to tobacco use. She also serves on the American Cancer Society’s Tobacco Cessation Task Group (National Lung Cancer Round Table). 

Jointly provided by Boston University School of Medicine and Rockpointe

     

The COPD Foundation’s Mission is to prevent and cure Chronic Obstructive Pulmonary Disease and improve the lives of all people affected by COPD.

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.